While overall risk of macular degeneration remained low, a study suggests that GLP-1 drugs may have increased that risk in ...

An Otsuka drug succeeded in a Phase 3 study in a chronic kidney disease, with results that outperformed a competitor's recent ...

WASHINGTON — President Trump declared Medicare off-limits several months ago, but Republicans are now considering ways to ...

From 2020 to 2024, universities contributed patents underpinning 50% of FDA-approved drugs. 87% of those academic ...

After becoming popular in the wake of the Me Too movement, at-home sexual assault kits are still facing legal battles. Things ...

Novo Nordisk’s stock has tumbled over 50% since its peak around a year ago, and it just ousted its CEO. Former employees say ...

A large government study published Thursday shows more definitively than ever before that Americans’ self-reported race is a ...

This week on "The Readout LOUD" podcast: an AI experiment at the FDA and how Novo Nordisk is trailing in the obesity drug ...

With millions of people at risk of losing health insurance under Trump’s tax bill, lawmakers have begun lobbying the ...

A study shows levels of the amino acid taurine rise rather than fall over time, confounding the goal of dietary supplements ...

The former workers cited various reasons why they think Novo was cautious: its conservative culture and history of investing ...

And it’s never a bad time to re-read some of the team’s excellent, award-winning coverage on the company: Last week, key ...